Despite more than a decade of intensive investigation following identification of the defective gene in 1993 (Latif et al. 1993), the nature of the VHL tumor suppressor mechanism and how it relates to the physiological function of VHL remains unclear (Kaelin 2002). This evidence concerns the gene VHL and neoplasm.